成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 273-62-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 273-62-1
Chemical Structure| 273-62-1
Structure of 273-62-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 273-62-1 ]

Related Doc. of [ 273-62-1 ]

Alternatived Products of [ 273-62-1 ]
Product Citations

Product Details of [ 273-62-1 ]

CAS No. :273-62-1 MDL No. :MFCD13175184
Formula : C6H4N2O Boiling Point : -
Linear Structure Formula :- InChI Key :BFPLMTPHDFFMTG-UHFFFAOYSA-N
M.W : 120.11 Pubchem ID :19831830
Synonyms :

Calculated chemistry of [ 273-62-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 31.8
TPSA : 38.92 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.3 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : 1.03
Log Po/w (WLOGP) : 1.22
Log Po/w (MLOGP) : 0.16
Log Po/w (SILICOS-IT) : 1.54
Consensus Log Po/w : 1.08

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.97
Solubility : 1.28 mg/ml ; 0.0106 mol/l
Class : Very soluble
Log S (Ali) : -1.44
Solubility : 4.39 mg/ml ; 0.0365 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.49
Solubility : 0.387 mg/ml ; 0.00322 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.18

Safety of [ 273-62-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 273-62-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 273-62-1 ]

[ 273-62-1 ] Synthesis Path-Downstream   1~3

  • 1
  • <i>N</i>-<2-oxo-1,2-dihydro-<3>pyridyl>-formamide [ No CAS ]
  • [ 273-62-1 ]
  • 2
  • [ 16867-03-1 ]
  • [ 122-51-0 ]
  • [ 273-62-1 ]
YieldReaction ConditionsOperation in experiment
With toluene-4-sulfonic acid; at 140℃; for 8h; Reference H Synthesis of 2 [(S)-(TERT-BUTOXYCARBONYL) AMINO-L-(OXAZOLO] [4, [5-B] PYRIDIN-2-YL) BUTAN-1-OL] Step 1 A mixture of 2-amino-3-hydroxypyridine (11 g, 100 mmol), triethylorthoformate (80 mL) and p-toluenesulfonic acid (61 mg) was heated at [140 C] for 8 h. Excess triethylorthoformate was removed under vacuum and oxazolo [4, [5-B]] pyridine was crystalized from ethyl acetate (9 g). Step 2 In a clean roundbottom flask equipped with stir bar was placed oxazolo [4,5- [B]] pyridine (600 mg, 5 mmol) in THF (30 mL) and the reaction mixture was cooled to [0 C] under N2 atomosphere. Isopropylmagnesium chloride (2 M in THF, 2.5 mL, 5 mmol) was added. After stirring for 1 h at 0 [C,] [(USD)-2-(TERT-BUTOXYCARBONYL)] aminobutyraldehyde (573 mg, 3 mmol) in THF (20 mL) was added. The ice bath was removed and the reaction mixture was allowed to warm to room temperature. After 2 h, the reaction mixture was quenched with saturated ammonium chloride solution and concentrated to dryness. The residue was extracted with EtOAc, then washed with brine, dried with anhyd. [MGS04,] filtered and concentrated. The crude product was purified by chromatograph to yield 383 mg of the desired compound.
  • 3
  • [ 153371-25-6 ]
  • [ 273-62-1 ]
  • [ 477940-25-3 ]
YieldReaction ConditionsOperation in experiment
Reference H Synthesis of 2 [(S)-(TERT-BUTOXYCARBONYL) AMINO-L-(OXAZOLO] [4, [5-B] PYRIDIN-2-YL) BUTAN-1-OL] Step 1 A mixture of 2-amino-3-hydroxypyridine (11 g, 100 mmol), triethylorthoformate (80 mL) and p-toluenesulfonic acid (61 mg) was heated at [140 C] for 8 h. Excess triethylorthoformate was removed under vacuum and oxazolo [4, [5-B]] pyridine was crystalized from ethyl acetate (9 g). Step 2 In a clean roundbottom flask equipped with stir bar was placed oxazolo [4,5- [B]] pyridine (600 mg, 5 mmol) in THF (30 mL) and the reaction mixture was cooled to [0 C] under N2 atomosphere. Isopropylmagnesium chloride (2 M in THF, 2.5 mL, 5 mmol) was added. After stirring for 1 h at 0 [C,] [(USD)-2-(TERT-BUTOXYCARBONYL)] aminobutyraldehyde (573 mg, 3 mmol) in THF (20 mL) was added. The ice bath was removed and the reaction mixture was allowed to warm to room temperature. After 2 h, the reaction mixture was quenched with saturated ammonium chloride solution and concentrated to dryness. The residue was extracted with EtOAc, then washed with brine, dried with anhyd. [MGS04,] filtered and concentrated. The crude product was purified by chromatograph to yield 383 mg of the desired compound.
Reference R Synthesis of [(S)-2-AMINO-1-OXAZOLO] [4,5-b] pyridin-2-yl-butan-1-ol Step 1 A mixture of 2-amino-3-hydroxypyridine (25 g, 227 mmol), triethylorthoformate (75 mL) and p-toluenesulfonic acid (61 mg) was heated at [140 C] for 8 h. Excess triethylorthoformate was removed under vacuum. The product was crystallized from ethyl acetate to yield 22.5 g of oxazolo [4,5-b] pyridine. Step 2 To a stirred solution of the oxazolo [4,5-b] pyridine (12 g, 100 mmol) in THF (300 mL) was added n-BuLi (1.6 M solution in 62.5 mL of hexane) drop wise under N2 at-78 [C.] After 1 h, MgBr. [ET20] (25.8 g, 100 mmol) was added and the reaction mixture was allowed to warm [TO-45 C] for 1 h before being treated with [(S)-2-BOC-AMINO-BUTYLALDEHYDE] (11.46 g, 60 mmol) in THF (50 mL). The reaction mixture was stirred for 1 h, quenched with saturated [NH4C1,] and extracted with ethyl acetate. The organic layer was washed with brine, dried with MgS04 and concentrated. The residue was purified by silica gel column chromatography to yield (S)-2-Boc-amino-l-(oxazolo [4,5-b] pyridin-2-yl)-1-butanol (14.1 g). Step 3 [(S)-2-BOC-AMINO-L-(OXAZOLO] [4,5-b] pyridin-2-yl)-1-butanol (311 mg, 1 mmol) and MeCl2 (5mL) were mixed and TFA [(LML)] was added at room temperature. After stirring for 1 h, the solvent and excess TFA were removed under vacuum to produce 355 mg of [(USD)-2-] [AMINO-L-OXAZOLO] [4,5-b] [PYRIDIN-2-YL-BUTAN-1-OL.] TFA salt.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Parent Nucleus of
[ 273-62-1 ]

Other Aromatic Heterocycles

Chemical Structure| 116081-18-6

[ 116081-18-6 ]

6-Bromo-2-methyloxazolo[5,4-b]pyridine

Similarity: 0.81

Chemical Structure| 169205-95-2

[ 169205-95-2 ]

2-(Methylthio)oxazolo[4,5-b]pyridine

Similarity: 0.74

Chemical Structure| 273-56-3

[ 273-56-3 ]

Oxazolo[4,5-c]pyridine

Similarity: 0.66

Chemical Structure| 3243-24-1

[ 3243-24-1 ]

1H-Imidazo[4,5-c]pyridin-4-ol

Similarity: 0.65

Chemical Structure| 20686-65-1

[ 20686-65-1 ]

2-Methylnaphtho[2,1-d]oxazole

Similarity: 0.63

; ;